Cocrystal Enables Fixed-Dose Empagliflozin and Metformin Bilayer for Bioequivalence
A new approach to diabetes treatment has moved from the bench to the bedside: researchers report a cocrystal-enabled, bilayer fixed-dose ...
A new approach to diabetes treatment has moved from the bench to the bedside: researchers report a cocrystal-enabled, bilayer fixed-dose ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine